Product Images Losortan Potassium

This appears to be a partial data report from a study comparing the effectiveness of Atenolol and Losartan Potassium on a primary endpoint. The adjusted risk reduction percentage is given as 13% with a P-value of 0.021. There are also some numbers listed under "Study Month". It is unclear what these numbers represent.*

This appears to be a graph or chart showing the percentage of patients who experienced a fatal or non-fatal stroke while taking either Atenolol or Losartan Potassium, along with an adjusted risk reduction percentage and a p-value. Not enough context is given to provide a more detailed description or interpretation of the data.*

This appears to be a table for a clinical trial comparing Losartan Potassium tablets to a placebo for an unknown medical condition. The table displays the percentage of patients experiencing an "event" categorized by those who had zero events and those who had 20 or more events. The data suggests that the risk reduction for patients using Losartan Potassium tablets is 16.1% with a p-value of 0.022. The significance of these numbers cannot be determined without additional context.*

This appears to be a label from a medication bottle. The medication is Losartan, which is in the form of a white capsule. Potassium tablets with a strength of 25mg are also mentioned on the label. The manufacturer appears to be Cadila Healthcare Ltd. The label also provides storage instructions and the expiration date.*